Redox bioenergetics of neuronal senescence in Alzheimer's disease
Mitochondrial energy failure and cellular aging drive Alzheimer's disease development, suggesting new drug targets that tackle these foundational processes.
This mechanistic review from Istanbul proposes a framework in which redox imbalance, cellular senescence, and neurodegeneration are interdependent drivers of Alzheimer's disease, with energy failure and oxidative stress preceding classic pathological hallmarks. Implications for senolytic and mitochondria-targeted therapeutic strategies are discussed.
What the study was
- Study design
- Narrative review
- Category
- Other
- Maturity
- Exploratory
- Journal
- International Review of Neurobiology
Why it surfaced
Mechanism-level review on AD neuronal senescence; relevant to aging/longevity topic but limited clinical actionability at this stage.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.